Fingerprint
Dive into the research topics where Investigational Cancer Therapeutics is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Advances in Targeting HER2 across Cancer Subtypes: A Pan-Tumor Approach
Adesoye, T., Dumbrava, E. E., Raghav, K. P. S., Sahin, A. A., Chen, H., Lee, S. S., Javle, M. M., Pant, S., Alhalabi, O., Le, X., Valero, V., Pohlmann, P. R. & Meric-Bernstam, F., Jan 15 2026, In: Clinical Cancer Research. 32, 2, p. 260-290 31 p.Research output: Contribution to journal › Review article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
A multi-institutional perspective on tarlatamab administration and management of CRS/ICANS
Zhang, B., Alder, L., Rosner, S., Desai, A., Cooper, A. J., Yimer, H., Bogdanska, W., Naqash, A. R., Taylor, A., Joshi, U., Carlisle, J., Champiat, S., Altan, M., Vega, M. F., Halm, J., Manzano, J. G., Fenton, G., Nie, Y., Wang, K. & Parma, M. & 5 others, , Jan 2026, In: Lung Cancer. 211, 108870.Research output: Contribution to journal › Article › peer-review
-
An Integrated Nonclinical and Clinical Risk Assessment of the Effects of Investigational ATRi Tuvusertib on QTc Interval in Patients With Solid Tumors
Mukker, J. K., Yap, T. A., Tolcher, A. W., de Bono, J. S., Plummer, R., Grosser, G., van Amsterdam, C., Schieferstein, H., Witjes, H., Diderichsen, P. M., Krebs-Brown, A., Gao, W., Strotmann, R., Szucs, Z., Gounaris, I. & Venkatakrishnan, K., Feb 2026, In: Clinical and translational science. 19, 2, e70496.Research output: Contribution to journal › Article › peer-review
Open Access